Cabrera-Domínguez JJ, et al. - Experts aspired to assess prospectively the behavior of narrow-diameter (3.3-mm) titanium-zirconium alloy implants with a hydrophilic surface (Straumann Roxolid SLActive) in patients with type 2 diabetes mellitus in single-unit restorations, compared with a healthy control group (assessed using the glycosylated hemoglobin HbA1c test). With regard to the investigated parameters, patients with glycemic control showed similar outcomes to healthy individuals. As per findings, in type 2 diabetic patients, the titanium-zirconium alloy small-diameter implants could be used in the anterior region of the mouth.